< + > Auvelity, Newly Approved Drug For Major Depressive Disorder, To Face Payer Pricing And Reimbursement Challenges

Overcoming market access hurdles will be a challenge for Auvelity’s sponsor, Axsome Therapeutics. But, a favorable efficacy and safety profile will likely help to facilitate patient access.